Fluoxetine reduces food intake by a cholecystokinin-independent mechanism
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 35 (1) , 51-54
- https://doi.org/10.1016/0091-3057(90)90203-t
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Reversal of the anorectic effect of (+)‐fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK‐329British Journal of Pharmacology, 1990
- A behavioural profile of fluoxetine-induced anorexiaPsychopharmacology, 1989
- Mechanisms of effects of d-Fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus releasePharmacology Biochemistry and Behavior, 1988
- The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokininBritish Journal of Pharmacology, 1988
- Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokininLife Sciences, 1988
- Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selectionPhysiology & Behavior, 1988
- Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the ratNeuropharmacology, 1985
- Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feedingJournal of Pharmacy and Pharmacology, 1976
- Cholecystokinin elicits the complete behavioral sequence of satiety in rats.Journal of Comparative and Physiological Psychology, 1975
- EFFECTS OF IMMOBILIZATION AND FOOD DEPRIVATION ON RAT BRAIN TRYPTOPHAN METABOLISMJournal of Neurochemistry, 1972